Skip to content

Questionnaire and Laboratory Data on Vitiligo Vulgaris

Demographic and Laboratory Data Collection for Patients With Vitiligo Vulgaris

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01206374
Enrollment
57
Registered
2010-09-21
Start date
2010-08-31
Completion date
2014-09-30
Last updated
2015-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitiligo Vulgaris

Keywords

Vitiligo Vulgaris

Brief summary

Vitiligo vulgaris is an autoimmune disorder that causes loss of pigmentation over the skin, hair and mucous membranes (e.g. lips, nose, genitals). While genes have been identified that are thought to be required for development of vitiligo, only 5-10% of relatives develop disease. The triggers for disease onset have not yet been identified. The intent of this study is to research trends in laboratory data, social and medical history that may be contributory to vitiligo onset, location of disease, course of illness and response to therapy.

Detailed description

Patients who participate in this study will be asked to complete a survey and have blood/ laboratory testing performed that relates or may relate to the diagnosis of vitiligo.

Interventions

None listed

Sponsors

Beth Israel Medical Center
CollaboratorOTHER
St. Luke's-Roosevelt Hospital Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Diagnosis of Vitiligo Vulgaris * Ability to sign consent

Exclusion criteria

* Pregnant * Inability to sign consent * Inability to complete questionnaire

Design outcomes

Primary

MeasureTime frameDescription
Quality of life disturbances in people with vitiligopoint prevalencedermatology life quality indices were you used and correlated with location of disease

Secondary

MeasureTime frameDescription
self-reporting of vitiligo disease symptoms and historysingle surveyCorrelation of the patient survey response with chart documentation was performed.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026